Bilibili Inc.: Form 20-F for the period ended Dec 31, 2021
Filed with the SEC on Apr 25, 2022 and accepted by EDGAR at Apr 25, 2022, 06:24 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2021-01-01 to 2021-12-31 | $3.04bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2021-01-01 to 2021-12-31 | $2.41bn | us-gaap:CostOfRevenue |
| Gross profit | 12 months2021-01-01 to 2021-12-31 | $634.5m | us-gaap:GrossProfit |
| Research and development | 12 months2021-01-01 to 2021-12-31 | $445.6m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2021-01-01 to 2021-12-31 | −$1.01bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2021-01-01 to 2021-12-31 | $24.4m | us-gaap:InterestExpense |
| Income tax | 12 months2021-01-01 to 2021-12-31 | $15.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2021-01-01 to 2021-12-31 | −$1.07bn | us-gaap:ProfitLoss |
| Diluted EPS | 12 months2021-01-01 to 2021-12-31 | −$2.80 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2021-01-01 to 2021-12-31 | −$2.80 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 12 months2021-01-01 to 2021-12-31 | −$415.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2021-01-01 to 2021-12-31 | $151.5m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2021-12-31 | $1.18bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-12-31 | $5.72bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-12-31 | $8.17bn | us-gaap:Assets |
| Current liabilities | At period end2021-12-31 | $1.89bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-12-31 | $4.76bn | us-gaap:Liabilities |
| Long-term debt | At period end2021-12-31 | $2.79bn | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2021-12-31 | $193.3m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2021-12-31 | $3.41bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-22-116261. Last ingested by Listed: Nov 6, 2026, 12:21 ET. Listed shows no prices and gives no investment advice.